Please note this UK-wide interim clinical access policy and accompanying clinical guide have now become ‘legacy’ documents.
Access to these COVID treatments should be guided by NICE’s COVID-19 rapid guideline as outlined in HSS(MD) 19/2023.
Please note this UK-wide interim clinical access policy and accompanying clinical guide have now become ‘legacy’ documents.
Access to these COVID treatments should be guided by NICE’s COVID-19 rapid guideline as outlined in HSS(MD) 19/2023.
Interim Clinical Commissioning Policy Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over)